Weight loss medications like Ozempic, Wegovy, and Mounjaro are not only effective in curbing appetite but also in reducing ...

While surgery has a low risk for complications, when they do occur, they are serious. This may explain why only 5%-10% of ...

In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of ...

About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 (GLP-1) receptor agonists and GLP-1/glucose-dependent insulinotropic polypeptide ...

Medically reviewed by Peter Weiss, MD Ozempic is the brand name of a medication called semaglutide, a glucagon-like peptide-1 ...

Four oral glucagon-like peptide-1 receptor (GLP1R) drugs, currently under Phase III trials, are in the race for approval, ...

The investment landscape has transformed since the presidential election, with small-cap stocks gaining momentum. The Russell ...

BioNxt Solutions announces development of sublingual thin-film ODF for Semaglutide: Vancouver, BC Tuesday, December 3, 2024, 17:00 Hrs [IST] BioNxt Solutions Inc., a bioscience co ...

poll finding that one in eight adult Americans has taken a Glucagon-like peptide-1 (GLP-1), the technical name for ...

A study finds that anti-obesity medications may help reduce alcohol consumption, with nearly half of participants in weight ...

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...